prof. MUDr. Jiří Mayer, CSc.

2023

• Biomaterial selection does not affect AML engraftment in humanized ossicles.

  ČULEN Martin LOJA Tomáš BUŠA Daniel HERUDKOVÁ Zdeňka HÝL Jan VLAŽNÝ Jakub LIŠKOVÁ K. REPKO Martin VOJTOVÁ Lucy MAYER Jiří

  Conference abstract

  Year: 2023, type: Conference abstract

• Bosutinib v terapii chronické myeloidní leukemie v každodenní praxi – analýzy z databáze INFINITY

  ČIČÁTKOVÁ Petra ŽÁČKOVÁ Daniela HORŇÁK Tomáš MAYER Jiří

  Conference abstract

  Year: 2023, type: Conference abstract

• Cévní nežádoucí účinky u pacientů s chronickou myeloidní leukemií při terapii inhibitory tyrozinkináz v každodenní klinické praxi – analýza z databáze INFINITY

  ČIČÁTKOVÁ Petra ŽÁČKOVÁ Daniela HORŇÁK Tomáš KLAMOVÁ H. BĚLOHLÁVKOVÁ P. STEJSKAL L. KŘÍSTKOVÁ Z. BARANOVÁ J. KVETKOVÁ Anežka SEMERÁD Lukáš PROCHÁZKOVÁ Jiřina MAYER Jiří

  Article in Periodical

  Transfuze a Hematologie Dnes, year: 2023, volume: 29, edition: 1, DOI

• European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives

  VALENT Peter HARTMANN Karin BONADONNA Patrizia SPERR Wolfgang NIEDOSZYTKO Marek KLUIN-NELEMANS Hanneke C HERMINE Olivier SOTLAR Karl HOERMANN Gregor NEDOSZYTKO Boguslaw BROESBY-OLSEN Sigurd ZANOTTI Roberta LANGE Magdalena DOUBEK Michael BROCKOW Knut ALVAREZ-TWOSE Ivan VARKONYI Judit YAVUZ Selim NILSSON Gunnar RADIA Deepti GRATTAN Clive SCHWAAB Juliana GILLEN Theo ELBERINK Hanneke N G Oude HAEGGLUND Hans SIEBENHAAR Frank HADZIJUSUFOVIC Emir SABATO Vito MAYER Jiří REITER Andreas ORFAO Alberto HORNY Hans-Peter TRIGGIANI Massimo AROCK Michel

  Article in Periodical

  JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, year: 2023, volume: 11, edition: 6, DOI

• Expansions of tumor-reactive Vdelta1 gamma-delta T cells in newly diagnosed patients with chronic myeloid leukemia

  KNIGHT Andrea PISKÁČEK Martin JURAJDA Michal PROCHÁZKOVÁ Jiřina RÁČIL Zdeněk ŽÁČKOVÁ Daniela MAYER Jiří

  Article in Periodical

  Cancer immunology, immunotherapy, year: 2023, volume: 72, edition: 5, DOI

• Exploring the mechanisms of Venetoclax resistence via drug screening and genome-wide CRISPR screening.

  LADUNGOVÁ Adriana PESCHELOVÁ Helena DOSTÁLOVÁ Lenka LODHI Yusuf GOTTUMUKKALA Narendra Varma MAYER Jiří ŠMÍDA Michal

  Conference abstract

  Year: 2023, type: Conference abstract

• FOX01-rictor AXIS induces AKT phosporylation during CLL cell adaptation to BCR inhibitors: Implications for combinatorial therapy.

  ONDRIŠOVÁ Laura ŠEDA Václav HOFERKOVÁ Eva CHIODIN G. HLAVÁČ Kryštof KOŠŤÁLOVÁ Lenka MLADONICKÁ PAVLASOVÁ Gabriela FILIP Daniel FARIA ZENI Pedro OPPELT Jan PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka SIMKOVIC M. VRBACKÝ F. LYSÁK Daniel FERNANDES SM. DAVIDS MS. MAIQUES-DIAZ A. CHARALAMPOPOULOU S. MARTIN-SUBERO JI. BROWN JR. DOUBEK Michael FORCONI F. MAYER Jiří MRÁZ Marek

  Conference abstract

  Year: 2023, type: Conference abstract

• FOXO1-RICTOR AXIS induces adaptive increase in AKT activity during BCR inhibitor therapy in CLL: Implications for combination therapy.

  ONDRIŠOVÁ Laura ŠEDA Václav CHIODIN Giorgia HLAVÁČ Kryštof KOŠŤÁLOVÁ Lenka FILIP Daniel FARIA ZENI Pedro PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka ŠIMKOVIČ Martin VRBACKÝ Filip LYSÁK Daniel FERNANDEZ Stacey M. DAVIDS MS. MAIQUES-DIAZ Alba CHARALAMPOPOULOU Stella MARTIN-SUBERO Jose I. BROWN Jennifer R. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

  Conference abstract

  Year: 2023, type: Conference abstract

• Foxo1-Rictor axis mediates adaptive increase in Akt activity and cell survival during BCR inhibitor therapy in chronic lymphocytic leukemia.

  HLAVÁČ Kryštof ONDRIŠOVÁ Laura ŠEDA Václav HOFERKOVÁ Eva CHIODIN G. KOŠŤÁLOVÁ Lenka MLADONICKÁ PAVLASOVÁ Gabriela FILIP Daniel FARIA ZENI Pedro OPPELT Jan PANOVSKÁ Anna PLEVOVÁ Karla POSPÍŠILOVÁ Šárka ŠIMKOVIČ M. VRBACKÝ F. LYSÁK Daniel FERNANDES SM. DAVIDS MS. MAIQUES-DIAZ A. CHARALAMPOPOULOU S. MARTIN-SUBERO I. BROWN JR. DOUBEK Michael FORCONI Francesco MAYER Jiří MRÁZ Marek

  Conference abstract

  Year: 2023, type: Conference abstract

• Gemtuzumab ozogamicin plus midostaurin in conjunction with standard intensive therapy for FLT3-mutated acute myeloid leukemia patients - Czech Center experience

  WEINBERGEROVÁ Barbora ČERŇAN Martin KABUT Tomáš SEMERÁD Lukáš PODSTAVKOVÁ Natália SZOTKOWSKI Tomáš JEŽÍŠKOVÁ Ivana MAYER Jiří

  Article in Periodical

  Haematologica, year: 2023, volume: 108, edition: 10, DOI